CCL5 and metabolic dysfunction-associated steatotic liver disease: While these data are in rodents, this finding in particular is interesting with respect to not only the actions of curcumin but also the possibility that serum RANTES levels could be a viable biomarker to monitor the progression of NAFLD/NASH.